ML20246E906

From kanterella
Jump to navigation Jump to search
Requests Executive Branch Position Re Ga Co Application for License to Export 4 Kg nuclear-grade Graphite to France. Necessary Assurance Ltr Should Be Obtained from Euratom for Application to Export 50.76 G Low Enriched U
ML20246E906
Person / Time
Site:
(XMAT-0340, XMAT-340, XSNM-2450)
Issue date: 04/28/1989
From: Peterson M
NRC OFFICE OF GOVERNMENTAL & PUBLIC AFFAIRS (GPA)
To: Thorne C
STATE, DEPT. OF, BUREAU OF OCEANS & INTL. ENVIRONMENT
References
NUDOCS 8905120059
Download: ML20246E906 (1)


Text

_ _ - -

p[m mm_m_m m m m a nLa m m m m m m m m m m m mm m m m m m m m m m m m m iTK9B"E'ET2T 1

3

/

NRC FsM m

"#GE O'

" AGE 5 g & so U.S. NUQ. EAR RfCULATORY COMMISSION MATERIALS LICENSE Amendment No. 32 Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, gf Code of Federal Regulations, Chapter I, Parts 30,31,32,33,34,35,40 and 70, and in reliance on statements and repre gl heretofore made by the licensee, a hcense is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct.

(! soarce, and special nuclear material designated below; to use such material for the purpose (s) and at the place (s) designated below;to N ' deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This kl

, license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended and is I subject to all applicable rules, regulations and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any a

conditions specified below.

j j!!

k In accordance with application received dl May 9, 1986 f.

1.

Robinson Memorial Hospital

3. License number 34-09621-01 is amended in g

its entirety to read as follows:

2.

6847 North Chestnut Street f

f Ravenna, OH 44266 lF 4; hp,irati$a hate August 31, 1993 4

s' eferen$ No./.

030-02789 6l 6. Byproduct, source, and/or

['

'. Chemical and/or physical

'v6. Maximum amount that licensee i

El special nuclear material form

'"gtnay passess at any one time I

j'

,under this license L

\\

l

,. ' {\\

A. As needed C

7',t;A.(Any..radiopharmaceutical%identifiedini10;CFR,!-

i A. Any byproduct material p

identified in 10 CFR

~ 735/100 TI F,J l

q 35.100

(!S

. B. Ariy :radi$p;hiirmaceutical $1 As needed

~

<;8 e

4 5!

B h

. Any byproduct materisl identified in 10 CFR'

identified in 10 CFR

(-

35.200 35.200 '

4 l;

t M

C. Any byproduct material C C. Any rididpharmaceuticaf ~ C. As needed k

identified in 10 CFR identified in 10 CFR 35.300 35.300 t

m

)

si D

D. Any brachytherapy source D. As needed h

. Any byproduct material identified in 10 CFR identified in 10 CFR

'4j 35.400 35.400 E. Any byproduct material E. Sealed sources identified E. As needed

-i identified in 10 CFR in 10 CFR 35.500 g

35.500

$l F. Any byproduct material F. Prepackaged Kits F. As needed

,l identified in 10 CFR I

Li 31.11 4

4 6

A l

t1 l

8904120059 880616 ;

g g

\\

REG 3 LIC30 PNU p l

34-09621-01 3

l

FMMMMMMMMMMMMMMMhmMMMMMMMMMMMMMMMMMM&MMmmn3mmmm33ggggg 2

3 I

ll CXC Faem 374A U.S. NUCLE AR CEEUL,ATORY COMMISSION PAGE OF PTGES ll"'

ucena number i

34-09621-01 l

MATERIALS LICENSE l

SUPPLEMENTARY SHEET 030-02789 l

u 1

Amendment No. 32 g

9.

Authorized Use:

l I

t A.

Medical use described in 10 CFR 35.100.

g I

N 4

B.

Medical use described in 10 CFR 35.200.

l-fl I

l C.

Medical use described in 10 CFR 35.300.

i t

l D.

Medical use described in 10 CFR 35.400.

W s

Medical use described in 10 CFR 35.500 in devices which have been evaluated and I

({

E.

approved for licensing purposes by'the 70.S. Nuclear Regulatory Commission or an h

q q

Agreement State, g

gl q

,, N.

ll 8

F.

In vitro studies.

p 4

h CONDITIONS 4

(

10.

Location of Use: '6847 North Chestnut Street, Ravenna, Ohio.

W r

l 11.

Radiation Safety Officer: Sonald! A. ' Hammel, (M.D.

12. Authorized Users:

M " --

l gi i!

Donald A. Hammel, M.D. Lfor material in.10 CFR 35.100, 35.200, 35.300 and 35.500, E

In-Vitro studies.

(j fl Manju Vigayvargiya, M.D. for material in 10 CFR 35.100, 35.200, 35.300 and 35.500, In-Vitro studies, g

il Rl A. Roger Tsai, M.D. for material in 10 CFR 35.200 (cardiac imaging and function

[

studies) and 35.500.

Albert James Cook, M.D. for material in 10 CFR 35.100, 35.200, 35.300, 35.400 and

{

35.500, In-Vitro studies.

W 4;

4!

David D.Y. Lan, M.D. for material in 10 CFR 35.100, 35.200, 35.300 and 35.500, i

[

In-Vitro studies.

f Michael D. McCloskey, M.D. for material in 10 CFR 35.100, 35.200, 35.300 and 35.50(,

In-Vitro studies.

dj Si 9;

13.

Pursuant to Title 10, Chapter 1, Code of Federal Regulations, Part 40, " Domestic Licensing of Source Material," the licensee is authorized to oossess, use, transfer,

f and import up to 999 kilograms of depleted uranium contained as shielding material q!

in the molybdenum-99/ technetium-99m generators authorized by this license.

4('

4!(

(!

(!

4?

NI COPY 0

}

ahm&M&mammmmmmmmm3mmmy f m & M M MM M WiiMIE mm MJEN.U.S. NUCLE AR REGULATORY,COMMIS$10N3 3

(l

)

wac r.,m 3MA

,,. G r pr pnces 1

l Lic:nne number

[,

7 h

MATERIALS LICENSE Docket or Reference number 030-02789 h!

i SUPPLEMENTARY SHEET I

o Amendment No. 32

}

j l

14.

The licensee will maintain brachytherapy sealed source handling equipment as b'

described in Appendix U, Subpart G of Regulatory Guide 10.8, August 1987.

P:

l0 l

l I

15.

This license is based on the licensee's statements and representations l

listed below.

A.

Application received May 9,1988 (with attachments).

j

-i-g q

5 l

4 4

4 4

1

'l l

1 N

l p

./

7 j

s, nl 4

i4 a

g!

d M

i 0

h

!i l

Si 9

4!

d li h

il lt il 1'

[

4 i

l

[j

$(!

h 4

I:j t,

i f3 I

(

D For he U.S. Nuclear Regulatory Commission 4:

N

'ilt

(

h i

i

(!

(

ginal Signed i1 f

Date: June 16, 1988 By y l 1 R. Madera jj r

trials Licensing Section, Region Ill l

gj l'

s COPY y

e t.